OTCMKTS:SHJBF Shanghai Junshi Biosciences (SHJBF) Stock Price, News & Analysis C$3.35 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Shanghai Junshi Biosciences Stock (OTCMKTS:SHJBF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SHJBF alerts:Sign Up Key Stats Today's RangeC$3.35▼C$3.3550-Day RangeC$3.35▼C$3.3552-Week RangeC$2.99▼C$4.23VolumeN/AAverage Volume1,000 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Shanghai Junshi Biosciences Co., Ltd. is a China-based biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative medicines. Its research activities cover oncology, autoimmune and inflammatory diseases, metabolic disorders, infectious diseases and other therapeutic areas, with programs based on monoclonal antibodies, small-molecule medicines and other biotechnology platforms. The company’s best-known product is toripalimab, an anti-PD-1 monoclonal antibody marketed in China under the brand name Tuoyi. Toripalimab has been developed for several cancer indications, including melanoma and nasopharyngeal carcinoma. In the United States, the product is marketed as Loqtorzi through a collaboration with Coherus BioSciences and received regulatory approval for certain nasopharyngeal carcinoma uses in 2023. Founded in 2012 and headquartered in Shanghai, Junshi Biosciences serves the Chinese market while pursuing international development and commercialization opportunities through regulatory submissions and partnerships. The company continues to advance a pipeline of candidates in oncology and other disease areas, supported by its drug-discovery, clinical-development and manufacturing capabilities.AI Generated. May Contain Errors. Read More Receive SHJBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Junshi Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SHJBF Stock News HeadlinesJunshi Biosciences Grants Reserved A Share Options Under 2025 Incentive SchemeSeptember 23, 2026 | tipranks.comShanghai Junshi Biosciences Board Confirms Option Plan Milestone and Cancels Some OptionsSeptember 23, 2026 | tipranks.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.October 3 at 1:00 AM | The Oxford Club (Ad)Shanghai Junshi Biosciences Sets Date for 2026 Interim Results Investor BriefingSeptember 4, 2026 | tipranks.comJunshi Biosciences Discloses Planned Stake Reduction by Key A-Share InvestorAugust 30, 2026 | tipranks.comShanghai Junshi Biosciences Ends 2026 Employee Stock Ownership SchemeAugust 26, 2026 | tipranks.comShanghai Junshi Biosciences Completes RMB0.7 Billion Technology Innovation Bond IssuanceAugust 21, 2026 | tipranks.comJunshi Biosciences Details Stake Reduction by Key Pre-IPO ShareholderAugust 19, 2026 | tipranks.comSee More Headlines SHJBF Stock Analysis - Frequently Asked Questions How have SHJBF shares performed this year? Shanghai Junshi Biosciences' stock was trading at C$3.08 at the beginning of the year. Since then, SHJBF stock has increased by 8.8% and is now trading at C$3.35. How do I buy shares of Shanghai Junshi Biosciences? Shares of SHJBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:SHJBF CIKN/A Webwww.junshipharma.com Phone86 21 6105 8800FaxN/AEmployees2,903Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:SHJBF) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Junshi Biosciences Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Junshi Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
